| Type |
Details |
Score |
| Publication |
| First Author: |
Gabai VL |
| Year: |
2012 |
| Journal: |
Mol Cell Biol |
| Title: |
Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR. |
| Volume: |
32 |
| Issue: |
5 |
| Pages: |
929-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen X |
| Year: |
2016 |
| Journal: |
PLoS One |
| Title: |
CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice. |
| Volume: |
11 |
| Issue: |
11 |
| Pages: |
e0165595 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Miranda-Carboni GA |
| Year: |
2008 |
| Journal: |
Genes Dev |
| Title: |
A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors. |
| Volume: |
22 |
| Issue: |
22 |
| Pages: |
3121-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sangrar W |
| Year: |
2015 |
| Journal: |
Oncogene |
| Title: |
Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems. |
| Volume: |
34 |
| Issue: |
31 |
| Pages: |
4109-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bentires-Alj M |
| Year: |
2007 |
| Journal: |
Cancer Res |
| Title: |
Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. |
| Volume: |
67 |
| Issue: |
6 |
| Pages: |
2420-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Oh S |
| Year: |
2018 |
| Journal: |
Cell Signal |
| Title: |
Egr-1 is required for neu/HER2-induced mammary tumors. |
| Volume: |
45 |
|
| Pages: |
102-109 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Petrova SC |
| Year: |
2020 |
| Journal: |
Oncotarget |
| Title: |
Regulation of breast cancer oncogenesis by the cell of origin's differentiation state. |
| Volume: |
11 |
| Issue: |
43 |
| Pages: |
3832-3848 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ahn R |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression. |
| Volume: |
8 |
|
| Pages: |
14638 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yori JL |
| Year: |
2014 |
| Journal: |
Cancer Res |
| Title: |
Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. |
| Volume: |
74 |
| Issue: |
17 |
| Pages: |
4762-71 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu H |
| Year: |
2023 |
| Journal: |
Int J Mol Sci |
| Title: |
Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations. |
| Volume: |
24 |
| Issue: |
10 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dong Y |
| Year: |
2014 |
| Journal: |
Cell Res |
| Title: |
Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis. |
| Volume: |
24 |
| Issue: |
11 |
| Pages: |
1354-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sheng G |
| Year: |
2021 |
| Journal: |
PLoS One |
| Title: |
Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist. |
| Volume: |
16 |
| Issue: |
3 |
| Pages: |
e0248996 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sizemore GM |
| Year: |
2017 |
| Journal: |
Oncogene |
| Title: |
Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1. |
| Volume: |
36 |
| Issue: |
16 |
| Pages: |
2297-2308 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grosset AA |
| Year: |
2016 |
| Journal: |
PLoS One |
| Title: |
Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer. |
| Volume: |
11 |
| Issue: |
11 |
| Pages: |
e0166731 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ursini-Siegel J |
| Year: |
2010 |
| Journal: |
Cancer Res |
| Title: |
Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response. |
| Volume: |
70 |
| Issue: |
20 |
| Pages: |
7776-87 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Andreani C |
| Year: |
2023 |
| Journal: |
Sci Rep |
| Title: |
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
22000 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Itah Z |
| Year: |
2023 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
HER2-driven breast cancer suppression by the JNK signaling pathway. |
| Volume: |
120 |
| Issue: |
4 |
| Pages: |
e2218373120 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rowson-Hodel AR |
| Year: |
2018 |
| Journal: |
Oncogene |
| Title: |
Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. |
| Volume: |
37 |
| Issue: |
2 |
| Pages: |
197-207 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hutchinson JN |
| Year: |
2004 |
| Journal: |
Cancer Res |
| Title: |
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. |
| Volume: |
64 |
| Issue: |
9 |
| Pages: |
3171-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
MacLennan MB |
| Year: |
2013 |
| Journal: |
J Nutr Biochem |
| Title: |
Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. |
| Volume: |
24 |
| Issue: |
1 |
| Pages: |
388-95 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pedersen K |
| Year: |
2009 |
| Journal: |
Mol Cell Biol |
| Title: |
A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis. |
| Volume: |
29 |
| Issue: |
12 |
| Pages: |
3319-31 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-ERBB3)1Slg/? Tg(MMTVneu)202Mul/? |
| Background: |
involves: FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Etv4/Etv4 Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul |
| Background: |
involves: FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2 Tg(Ckmm-cre)5Khn/? |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1 Tg(MMTV-Erbb2)NK1Mul/? |
| Background: |
involves: 129S4/SvJae * C57BL/6 * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2 Myl2/Myl2<+> |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(CAG-Has2)99Nita/? Tg(MMTVneu)202Mul/? |
| Background: |
FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Akt3/Akt3 Tg(MMTV-Erbb2)NK1Mul/Tg(MMTV-Erbb2)NK1Mul |
| Background: |
involves: 129 * C57BL/6 * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Pik3cb/Pik3cb Tg(MMTVneu)202Mul/? |
| Background: |
involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Pten/Pten Tg(MMTVneu)202Mul/? Tg(S100a4-cre)1Gle/? |
| Background: |
involves: FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1 Tg(MMTV-Erbb2)NK1Mul/? |
| Background: |
involves: 129S4/SvJae * C57BL/6 * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2<+> Pten/Pten<+> Tg(MMTV-cre)7Mul/? |
| Background: |
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2<+> Pten/Pten Tg(MMTV-cre)7Mul/? |
| Background: |
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1<+> Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)11233Kuw/? |
| Background: |
involves: 129S2/SvPas * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1<+> Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)10897Kuw/? |
| Background: |
involves: 129S2/SvPas * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)11233Kuw/? |
| Background: |
involves: 129S2/SvPas * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/? Tg(tetO-Ccnd1*T286A,-luc)10897Kuw/? |
| Background: |
involves: 129S2/SvPas * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ccnd1/Ccnd1 Tg(MMTVneu)202Mul/? |
| Background: |
involves: 129S2/SvPas * FVB/N |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-ERBB2*)#Arbs/? |
| Background: |
FVB-Tg(MMTV-ERBB2*)#Arbs |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
479
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
481
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
189
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
189
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
189
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sukhanova A |
| Year: |
2013 |
| Journal: |
Cancer Discov |
| Title: |
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. |
| Volume: |
3 |
| Issue: |
1 |
| Pages: |
96-111 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tao Y |
| Year: |
2016 |
| Journal: |
Carcinogenesis |
| Title: |
Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model. |
| Volume: |
37 |
| Issue: |
7 |
| Pages: |
731-739 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee D |
| Year: |
2009 |
| Journal: |
J Clin Invest |
| Title: |
Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. |
| Volume: |
119 |
| Issue: |
9 |
| Pages: |
2702-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ruan YC |
| Year: |
2014 |
| Journal: |
J Cell Sci |
| Title: |
CFTR interacts with ZO-1 to regulate tight junction assembly and epithelial differentiation through the ZONAB pathway. |
| Volume: |
127 |
| Issue: |
Pt 20 |
| Pages: |
4396-408 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yoshioka T |
| Year: |
2013 |
| Journal: |
J Clin Invest |
| Title: |
β4 Integrin signaling induces expansion of prostate tumor progenitors. |
| Volume: |
123 |
| Issue: |
2 |
| Pages: |
682-99 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vandekerckhove L |
| Year: |
2016 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk. |
| Volume: |
310 |
| Issue: |
7 |
| Pages: |
E495-504 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Porzia A |
| Year: |
2010 |
| Journal: |
J Immunol |
| Title: |
Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. |
| Volume: |
184 |
| Issue: |
8 |
| Pages: |
4170-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang C |
| Year: |
2004 |
| Journal: |
Am J Pathol |
| Title: |
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer. |
| Volume: |
164 |
| Issue: |
3 |
| Pages: |
1031-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cicchini M |
| Year: |
2014 |
| Journal: |
Autophagy |
| Title: |
Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. |
| Volume: |
10 |
| Issue: |
11 |
| Pages: |
2036-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ghidinelli M |
| Year: |
2017 |
| Journal: |
PLoS Biol |
| Title: |
Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination. |
| Volume: |
15 |
| Issue: |
6 |
| Pages: |
e2001408 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sinha VC |
| Year: |
2015 |
| Journal: |
Mol Cancer Res |
| Title: |
A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis. |
| Volume: |
13 |
| Issue: |
2 |
| Pages: |
231-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Seshadri S |
| Year: |
2010 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. |
| Volume: |
107 |
| Issue: |
12 |
| Pages: |
5622-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu FF |
| Year: |
2005 |
| Journal: |
Am J Physiol Heart Circ Physiol |
| Title: |
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. |
| Volume: |
289 |
| Issue: |
2 |
| Pages: |
H660-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schmucker J |
| Year: |
2003 |
| Journal: |
Glia |
| Title: |
erbB3 is dispensable for oligodendrocyte development in vitro and in vivo. |
| Volume: |
44 |
| Issue: |
1 |
| Pages: |
67-75 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Stankovic K |
| Year: |
2004 |
| Journal: |
J Neurosci |
| Title: |
Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. |
| Volume: |
24 |
| Issue: |
40 |
| Pages: |
8651-61 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Usui M |
| Year: |
2002 |
| Journal: |
J Bone Miner Res |
| Title: |
Enhancing effect of Tob deficiency on bone formation is specific to bone morphogenetic protein-induced osteogenesis. |
| Volume: |
17 |
| Issue: |
6 |
| Pages: |
1026-33 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dahlhoff M |
| Year: |
2013 |
| Journal: |
Biochim Biophys Acta |
| Title: |
Increased activation of the epidermal growth factor receptor in transgenic mice overexpressing epigen causes peripheral neuropathy. |
| Volume: |
1832 |
| Issue: |
12 |
| Pages: |
2068-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cadieux C |
| Year: |
2009 |
| Journal: |
Cancer Res |
| Title: |
Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. |
| Volume: |
69 |
| Issue: |
18 |
| Pages: |
7188-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Logan AM |
| Year: |
2017 |
| Journal: |
Glia |
| Title: |
Schwann cell-specific deletion of the endosomal PI 3-kinase Vps34 leads to delayed radial sorting of axons, arrested myelination, and abnormal ErbB2-ErbB3 tyrosine kinase signaling. |
| Volume: |
65 |
| Issue: |
9 |
| Pages: |
1452-1470 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Song X |
| Year: |
2015 |
| Journal: |
Cancer Res |
| Title: |
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas. |
| Volume: |
75 |
| Issue: |
6 |
| Pages: |
1035-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hoesl C |
| Year: |
2018 |
| Journal: |
Biochim Biophys Acta |
| Title: |
The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation. |
| Volume: |
1862 |
| Issue: |
4 |
| Pages: |
958-966 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cook RS |
| Year: |
2011 |
| Journal: |
Cancer Res |
| Title: |
ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis. |
| Volume: |
71 |
| Issue: |
11 |
| Pages: |
3941-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huebner RJ |
| Year: |
2014 |
| Journal: |
Development |
| Title: |
Developmental stratification of the mammary epithelium occurs through symmetry-breaking vertical divisions of apically positioned luminal cells. |
| Volume: |
141 |
| Issue: |
5 |
| Pages: |
1085-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu J |
| Year: |
2015 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. |
| Volume: |
463 |
| Issue: |
4 |
| Pages: |
1230-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kuns R |
| Year: |
2005 |
| Journal: |
Oncogene |
| Title: |
Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation. |
| Volume: |
24 |
| Issue: |
43 |
| Pages: |
6502-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Limpert AS |
| Year: |
2010 |
| Journal: |
J Biol Chem |
| Title: |
Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation. |
| Volume: |
285 |
| Issue: |
22 |
| Pages: |
16614-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Le TL |
| Year: |
2021 |
| Journal: |
J Clin Invest |
| Title: |
Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans. |
| Volume: |
131 |
| Issue: |
6 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Young CD |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. |
| Volume: |
6 |
| Issue: |
8 |
| Pages: |
e23205 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ueda O |
| Year: |
2017 |
| Journal: |
Sci Rep |
| Title: |
Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeutics. |
| Volume: |
7 |
|
| Pages: |
45839 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lemmens K |
| Year: |
2011 |
| Journal: |
Am J Physiol Heart Circ Physiol |
| Title: |
Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. |
| Volume: |
300 |
| Issue: |
3 |
| Pages: |
H931-42 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jo SA |
| Year: |
1995 |
| Journal: |
Nature |
| Title: |
Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. |
| Volume: |
373 |
| Issue: |
6510 |
| Pages: |
158-61 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bafico A |
| Year: |
1998 |
| Journal: |
Oncogene |
| Title: |
Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. |
| Volume: |
16 |
| Issue: |
21 |
| Pages: |
2819-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wagner M |
| Year: |
2002 |
| Journal: |
Gastroenterology |
| Title: |
Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. |
| Volume: |
122 |
| Issue: |
7 |
| Pages: |
1898-912 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang C |
| Year: |
2006 |
| Journal: |
Cancer Res |
| Title: |
Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. |
| Volume: |
66 |
| Issue: |
24 |
| Pages: |
11649-58 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wu Q |
| Year: |
2007 |
| Journal: |
Cancer Res |
| Title: |
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model. |
| Volume: |
67 |
| Issue: |
8 |
| Pages: |
3794-800 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Barrick CJ |
| Year: |
2008 |
| Journal: |
Toxicol Appl Pharmacol |
| Title: |
Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice. |
| Volume: |
228 |
| Issue: |
3 |
| Pages: |
315-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fehrenbacher N |
| Year: |
2008 |
| Journal: |
Cancer Res |
| Title: |
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. |
| Volume: |
68 |
| Issue: |
16 |
| Pages: |
6623-33 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu M |
| Year: |
2009 |
| Journal: |
Am J Pathol |
| Title: |
Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. |
| Volume: |
174 |
| Issue: |
5 |
| Pages: |
1910-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ingalla EQ |
| Year: |
2010 |
| Journal: |
J Biol Chem |
| Title: |
Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors. |
| Volume: |
285 |
| Issue: |
37 |
| Pages: |
28691-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu M |
| Year: |
2010 |
| Journal: |
Cancer Res |
| Title: |
The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. |
| Volume: |
70 |
| Issue: |
24 |
| Pages: |
10464-73 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu Y |
| Year: |
2013 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Neuregulin 1-β regulates cell adhesion molecule L1 expression in the cortex and hippocampus of mice. |
| Volume: |
441 |
| Issue: |
1 |
| Pages: |
7-12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Haricharan S |
| Year: |
2014 |
| Journal: |
Oncogene |
| Title: |
Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. |
| Volume: |
33 |
| Issue: |
50 |
| Pages: |
5729-39 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Torii T |
| Year: |
2014 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration. |
| Volume: |
452 |
| Issue: |
3 |
| Pages: |
782-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Memmi EM |
| Year: |
2015 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling. |
| Volume: |
112 |
| Issue: |
11 |
| Pages: |
3499-504 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Boulay PL |
| Year: |
2016 |
| Journal: |
Cancer Res |
| Title: |
Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression. |
| Volume: |
76 |
| Issue: |
9 |
| Pages: |
2662-74 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang L |
| Year: |
2016 |
| Journal: |
Am J Hum Genet |
| Title: |
Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing. |
| Volume: |
98 |
| Issue: |
5 |
| Pages: |
843-856 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Horiuchi D |
| Year: |
2016 |
| Journal: |
Nat Med |
| Title: |
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. |
| Volume: |
22 |
| Issue: |
11 |
| Pages: |
1321-1329 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Alizadeh A |
| Year: |
2017 |
| Journal: |
Glia |
| Title: |
Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. |
| Volume: |
65 |
| Issue: |
7 |
| Pages: |
1152-1175 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Simonis A |
| Year: |
2014 |
| Journal: |
PLoS Pathog |
| Title: |
Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells. |
| Volume: |
10 |
| Issue: |
6 |
| Pages: |
e1004160 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gupta MK |
| Year: |
2021 |
| Journal: |
Sci Rep |
| Title: |
Cardiac expression of microRNA-7 is associated with adverse cardiac remodeling. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
22018 |
|
•
•
•
•
•
|